SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study

NCT07515820 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: SHR-3821 and fruquintinib

Sponsor

Meng Qiu

Collaborators

[object Object]